Literature DB >> 15331390

Discrimination of human lung neoplasm from normal lung by two target genes.

Hans-Stefan Hofmann1, Gesine Hansen, Stefan Burdach, Babett Bartling, Rolf-Edgar Silber, Andreas Simm.   

Abstract

Simple tools for discrimination of lung tissues can be useful in a fast machine-aided diagnosis, for example, by tumor-specific microarrays. We demonstrate that an easy ratio technique, based on the expression levels of only two genes differentially expressed in lung tumor and normal lung samples, allows discrimination of normal and neoplastic lung with a sensitivity of 100% and specificity of 90.5%. DNA microarray analysis of 99 lung tumor samples and 15 normal lung tissues revealed that receptor for advanced glycation end products (RAGE) mRNA is reduced fourfold (p = 7.8 x 10(-11)) and cyclin-B2 mRNA is upregulated twofold (p = 5.9 x 10(-18)) in lung carcinoma compared with normal lung. The microarray-calculated expression ratio of RAGE to cyclin-B2 was used in polymerase chain reaction analysis of 84 independent blinded samples to discriminate tumor and corresponding normal lung tissues. In 94.7% of the samples this quotient correctly distinguished non-small cell lung cancer from normal lung tissue, suggesting the RAGE/cyclin-B2 quotient as a potential means for diagnosis of lung cancer.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15331390     DOI: 10.1164/rccm.200401-127OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  15 in total

1.  Lung inflammation biomarkers and lung function in children chronically exposed to arsenic.

Authors:  Edgar Olivas-Calderón; Rogelio Recio-Vega; A Jay Gandolfi; R Clark Lantz; Tania González-Cortes; Cesar Gonzalez-De Alba; John R Froines; Jorge A Espinosa-Fematt
Journal:  Toxicol Appl Pharmacol       Date:  2015-06-03       Impact factor: 4.219

2.  Differential diagnosis of solitary lung nodules with gene expression ratios.

Authors:  Gavin J Gordon; Levi A Deters; Matthew D Nitz; Barry C Lieberman; Beow Y Yeap; Raphael Bueno
Journal:  J Thorac Cardiovasc Surg       Date:  2006-09       Impact factor: 5.209

3.  Gene expression ratio test distinguishes normal lung from lung tumors in solid tissue and FNA biopsies.

Authors:  Assunta De Rienzo; Beow Y Yeap; Edmund S Cibas; William G Richards; Lingsheng Dong; Ritu R Gill; David J Sugarbaker; Raphael Bueno
Journal:  J Mol Diagn       Date:  2014-01-09       Impact factor: 5.568

4.  Prognostic potential and tumor growth-inhibiting effect of plasma advanced glycation end products in non-small cell lung carcinoma.

Authors:  Babett Bartling; Hans-Stefan Hofmann; Antonia Sohst; Yvonne Hatzky; Veronika Somoza; Rolf-Edgar Silber; Andreas Simm
Journal:  Mol Med       Date:  2011-05-24       Impact factor: 6.354

5.  Association of RAGE polymorphisms and cancer risk: a meta-analysis of 27 studies.

Authors:  Wenjie Xia; Youtao Xu; Qixing Mao; Gaochao Dong; Run Shi; Jie Wang; YanYan Zheng; Lin Xu; Feng Jiang
Journal:  Med Oncol       Date:  2015-01-21       Impact factor: 3.064

Review 6.  The receptor for advanced glycation end products (RAGE) and the lung.

Authors:  Stephen T Buckley; Carsten Ehrhardt
Journal:  J Biomed Biotechnol       Date:  2010-01-19

Review 7.  Making the case for molecular staging of malignant pleural mesothelioma.

Authors:  Raphael Bueno
Journal:  Semin Thorac Cardiovasc Surg       Date:  2009

8.  DUDA-Net: a double U-shaped dilated attention network for automatic infection area segmentation in COVID-19 lung CT images.

Authors:  Feng Xie; Zheng Huang; Zhengjin Shi; Tianyu Wang; Guoli Song; Bolun Wang; Zihong Liu
Journal:  Int J Comput Assist Radiol Surg       Date:  2021-06-05       Impact factor: 2.924

Review 9.  Receptor for Advanced Glycation End Products (RAGE) and Its Polymorphic Variants as Predictive Diagnostic and Prognostic Markers of NSCLCs: a Perspective.

Authors:  Tapan K Mukherjee; Parth Malik; John R Hoidal
Journal:  Curr Oncol Rep       Date:  2021-01-05       Impact factor: 5.075

10.  Elevated cyclin B2 expression in invasive breast carcinoma is associated with unfavorable clinical outcome.

Authors:  Emman Shubbar; Anikó Kovács; Shahin Hajizadeh; Toshima Z Parris; Szilárd Nemes; Katrin Gunnarsdóttir; Zakaria Einbeigi; Per Karlsson; Khalil Helou
Journal:  BMC Cancer       Date:  2013-01-02       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.